Dreyling, M., André, M., Gökbuget, N., Tilly, H., Jerkeman, M., Gribben, J. ... Salles, G. (2022). The EHA Research Roadmap: Malignant Lymphoid Diseases. HemaSphere, 6. (6). doi: 10.1097/HS9.0000000000000726
Dreyling, Martin, et al. "The EHA Research Roadmap: Malignant Lymphoid Diseases." HemaSphere, vol. 6, no. 6, 2022. https://doi.org/10.1097/HS9.0000000000000726
Dreyling, Martin, Marc André, Nicola Gökbuget, Hervé Tilly, Mats Jerkeman, John Gribben, Andrés Ferreri, et al. "The EHA Research Roadmap: Malignant Lymphoid Diseases." HemaSphere 6, no. 6 (2022). https://doi.org/10.1097/HS9.0000000000000726
Dreyling, M., et al. (2022) 'The EHA Research Roadmap: Malignant Lymphoid Diseases', HemaSphere, 6(6). doi: 10.1097/HS9.0000000000000726
Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, and sur.. The EHA Research Roadmap: Malignant Lymphoid Diseases. HemaSphere [Internet]. 2022 May 19 [cited 2024 August 17];6(6). doi: 10.1097/HS9.0000000000000726
M. Dreyling, et al., "The EHA Research Roadmap: Malignant Lymphoid Diseases", HemaSphere, vol. 6, no. 6, May 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:192801. [Accessed: 17 August 2024]